Literature DB >> 15548372

Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

Feng Jiang1, Zhengnan Yin, Nancy P Caraway, Ruiyun Li, Ruth L Katz.   

Abstract

To investigate the genomic aberrations that are involved in lung tumorigenesis and therefore may be developed as biomarkers for lung cancer diagnosis, we characterized the genomic copy number changes associated with individual genes in 14 tumors from patients with primary non small cell lung cancer (NSCLC). Six squamous cell carcinomas (SQCAs) and eight adenocarcinomas (ADCAs) were examined by high-resolution comparative genomic hybridization (CGH) analysis of cDNA microarray. The SQCAs and ADCAs shared common frequency distributions of recurrent genomic gains of 63 genes and losses of 72 genes. Cluster analysis using 57 genes defined the genomic differences between these two major histologic types of NSCLC. Genomic aberrations from a set of 18 genes showed distinct difference of primary ADCAs from their paired normal lung tissues. The genomic copy number of four genes was validated by fluorescence in situ hybridization of 32 primary NSCLC tumors, including those used for cDNA microarray CGH analysis; a strong correlation with cDNA microarray CGH data emerged. The identified genomic aberrations may be involved in the initiation and progression of lung tumorigenesis and, most importantly, may be developed as new biomarkers for the early detection and classification of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548372      PMCID: PMC1531667          DOI: 10.1593/neo.04142

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  60 in total

1.  Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells.

Authors:  B Eickhoff; S Rüller; T Laue; G Köhler; C Stahl; M Schlaak; J van der Bosch
Journal:  Biol Chem       Date:  2000-02       Impact factor: 3.915

2.  Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma.

Authors:  A Rácz; N Brass; M Höfer; G W Sybrecht; K Remberger; E U Meese
Journal:  Int J Oncol       Date:  2000-07       Impact factor: 5.650

3.  Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  I Petersen; M Bujard; S Petersen; G Wolf; A Goeze; A Schwendel; H Langreck; K Gellert; M Reichel; K Just; S du Manoir; T Cremer; M Dietel; T Ried
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

4.  Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

Authors:  L Girard; S Zöchbauer-Müller; A K Virmani; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

5.  Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.

Authors:  A Kamimura; M Kamachi; J Nishihira; S Ogura; H Isobe; H Dosaka-Akita; A Ogata; M Shindoh; T Ohbuchi; Y Kawakami
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

6.  Expression of the genetic variants of human alpha-1-acid glycoprotein in cancer.

Authors:  J C Duché; S Urien; N Simon; E Malaurie; I Monnet; J Barré
Journal:  Clin Biochem       Date:  2000-04       Impact factor: 3.281

7.  The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

Authors:  M I Lerman; J D Minna
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

8.  Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status.

Authors:  G Mariatos; V G Gorgoulis; P Zacharatos; A Kotsinas; T Vogiatzi; G Rassidakis; P Foukas; T Liloglou; D Tiniakos; N Angelou; E N Manolis; M Veslemes; J K Field; C Kittas
Journal:  Int J Cancer       Date:  2000-03-20       Impact factor: 7.396

9.  Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers.

Authors:  S G Isler; S Schenk; I Bendik; P Schraml; H Novotna; H Moch; G Sauter; C U Ludwig
Journal:  Int J Oncol       Date:  2001-03       Impact factor: 5.650

10.  Rapid detection of IgH/BCL2 rearrangement in follicular lymphoma by interphase fluorescence in situ hybridization with bacterial artificial chromosome probes.

Authors:  Feng Jiang; Fan Lin; Roger Price; Jun Gu; L Jeffrey Medeiros; Hua Z Zhang; Su-Su Xie; Nancy P Caraway; Ruth L Katz
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

View more
  31 in total

1.  Sarcomatoid carcinomas of the lung--are these histogenetically heterogeneous tumors?

Authors:  Markus Blaukovitsch; Iris Halbwedl; Hannelore Kothmaier; Margit Gogg-Kammerer; Helmut H Popper
Journal:  Virchows Arch       Date:  2006-08-29       Impact factor: 4.064

Review 2.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

Review 3.  Small nucleolar RNAs functioning and potential roles in cancer.

Authors:  Nithyananda Thorenoor; Ondrej Slaby
Journal:  Tumour Biol       Date:  2014-11-25

Review 4.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

5.  Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer.

Authors:  Feng Jiang; Nevins W Todd; Qi Qiu; Zhenqiu Liu; Ruth L Katz; Sanford A Stass
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

6.  SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.

Authors:  Thomas Hussenet; Soraya Dali; Julien Exinger; Ben Monga; Bernard Jost; Doulaye Dembelé; Nadine Martinet; Christelle Thibault; Joerg Huelsken; Elisabeth Brambilla; Stanislas du Manoir
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

7.  Array CGH reveals genomic aberrations in human emphysema.

Authors:  Jin Soo Choi; Woon Jeong Lee; Seung Ho Baik; Hyoung Kyu Yoon; Kweon-Haeng Lee; Yeul Hong Kim; Young Lim; Young-Pil Wang
Journal:  Lung       Date:  2009-04-08       Impact factor: 2.584

8.  Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.

Authors:  J Wang; X Tian; R Han; X Zhang; X Wang; H Shen; L Xue; Y Liu; X Yan; J Shen; K Mannoor; J Deepak; J M Donahue; S A Stass; L Xing; F Jiang
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

Review 9.  Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review).

Authors:  Mudit Vaid; Joanna Floros
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

10.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.